IMMUNOREACTIVITY OF CHIMERIC PROTEINS CARRYING THE HIV-1 EPITOPE IGPGRAF - CORRELATION BETWEEN PREDICTED CONFORMATION AND ANTIGENICITY

被引:19
作者
TISMINETZKY, SG
SCODELLER, EA
EVANGELISTI, P
CHEN, YD
SCHIAPPACASSI, M
PORRO, F
BIZIK, F
ZACCHI, T
LUNAZZI, G
MIERTUS, S
BARALLE, FE
机构
[1] INT CTR GENET ENGN & BIOTECHNOL,I-34012 TRIESTE,ITALY
[2] USL 1,CATTINARA HOSP,TRIESTE,ITALY
[3] UNIDO,INT INST PURE & APPL CHEM,I-34012 TRIESTE,ITALY
关键词
EPITOPE PRESENTATION SYSTEM; HIV-1; V3; LOOP; EPITOPE CONFORMATION; SERUM IMMUNOREACTIVITY;
D O I
10.1016/0014-5793(94)00972-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sera from HIV-1 infected individuals were examined for their reactivity to the principal neutralizing domain, IGPGRAF sequence, of the V3-loop of HIV-1. Four hybrid proteins carrying this sequence inserted in four different outer loops of a protein that makes up the capsid of an insect virus were used as antigen in a Western blot assay for this survey. All the four antigens showed different activity: sera that recognise all antigens to sera that reacted with only one of them. Competition experiments indicated that the antibodies recognised these proteins with different affinity. Molecular modelling of the hybrid proteins predicted that the inserted sequence adopted different conformations in each position. Comparison of predicted most stable conformations for IGPGRAF indicated that there is a close relationship between conformational similarity to a V3-loop reference structure and the degree of reactivity with sera.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 26 条
  • [1] [Anonymous], 1980, PRACTICAL METHODS OP
  • [2] NEUTRALIZATION OF MULTIPLE LABORATORY AND CLINICAL ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) BY ANTISERA RAISED AGAINST GP120 FROM THE MN ISOLATE OF HIV-1
    BERMAN, PW
    MATTHEWS, TJ
    RIDDLE, L
    CHAMPE, M
    HOBBS, MR
    NAKAMURA, GR
    MERCER, J
    EASTMAN, DJ
    LUCAS, C
    LANGLOIS, AJ
    WURM, FM
    GREGORY, TJ
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (07) : 4464 - 4469
  • [3] PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160
    BERMAN, PW
    GREGORY, TJ
    RIDDLE, L
    NAKAMURA, GR
    CHAMPE, MA
    PORTER, JP
    WURM, FM
    HERSHBERG, RD
    COBB, EK
    EICHBERG, JW
    [J]. NATURE, 1990, 345 (6276) : 622 - 625
  • [4] DNAK-MEDIATED ALTERATIONS IN HUMAN GROWTH-HORMONE PROTEIN INCLUSION-BODIES
    BLUM, P
    VELLIGAN, M
    LIN, N
    MATIN, A
    [J]. BIO-TECHNOLOGY, 1992, 10 (03): : 301 - 304
  • [5] STRUCTURE AND ENERGETICS OF LIGAND-BINDING TO PROTEINS - ESCHERICHIA-COLI DIHYDROFOLATE REDUCTASE TRIMETHOPRIM, A DRUG-RECEPTOR SYSTEM
    DAUBEROSGUTHORPE, P
    ROBERTS, VA
    OSGUTHORPE, DJ
    WOLFF, J
    GENEST, M
    HAGLER, AT
    [J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1988, 4 (01): : 31 - 47
  • [6] ORDERED DUPLEX RNA CONTROLS CAPSID ARCHITECTURE IN AN ICOSAHEDRAL ANIMAL VIRUS
    FISHER, AJ
    JOHNSON, JE
    [J]. NATURE, 1993, 361 (6408) : 176 - 179
  • [7] GHIARA JB, 1994, SCIENCE, V264, P83
  • [8] IMMUNIZATION OF CHIMPANZEES CONFERS PROTECTION AGAINST CHALLENGE WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    GIRARD, M
    KIENY, MP
    PINTER, A
    BARRESINOUSSI, F
    NARA, P
    KOLBE, H
    KUSUMI, K
    CHAPUT, A
    REINHART, T
    MUCHMORE, E
    RONCO, J
    KACZOREK, M
    GOMARD, E
    GLUCKMAN, JC
    FULTZ, PN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) : 542 - 546
  • [9] NEUTRALIZATION OF DIVERSE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS BY AN ANTI-V3 HUMAN MONOCLONAL-ANTIBODY
    GORNY, MK
    CONLEY, AJ
    KARWOWSKA, S
    BUCHBINDER, A
    XU, JY
    EMINI, EA
    KOENIG, S
    ZOLLAPAZNER, S
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (12) : 7538 - 7542
  • [10] GORNY MK, 1993, J IMMUNOL, V150, P635